Tycoon Group Holdings Limited

HKSE 3390.HK

Tycoon Group Holdings Limited Price to Sales Ratio (P/S) on January 14, 2025: 2.32

Tycoon Group Holdings Limited Price to Sales Ratio (P/S) is 2.32 on January 14, 2025, a -32.33% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Tycoon Group Holdings Limited 52-week high Price to Sales Ratio (P/S) is 4.04 on January 31, 2024, which is 73.87% above the current Price to Sales Ratio (P/S).
Tycoon Group Holdings Limited 52-week low Price to Sales Ratio (P/S) is 2.27 on December 19, 2024, which is -2.07% below the current Price to Sales Ratio (P/S).
Tycoon Group Holdings Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 2.69.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

HKSE: 3390.HK

Tycoon Group Holdings Limited

CEO	Mr. Ka Chun Wong
IPO Date	April 15, 2020
Location	Hong Kong
Headquarters	Wah Wai Centre
Employees	250
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Tycoon Group Holdings Limited, an investment holding company, distributes and retails a suite of health and well-being related products in Hong Kong, Mainland China, Macau, and internationally. It operates through three segments: Distribution, E-Commerce, and Retail Stores. The company offers proprietary Chinese medicine, health supplement, skin care, personal care, and other healthcare products under the third-party and private label brands. It sells its products to chain retailers, non-chain retailers, and traders; and through its brick-and-mortar retail stores as well as online stores. The company was founded in 2015 and is headquartered in Shatin, Hong Kong.

Key trends

Past 5 years